Article citationsMore>>

E. S. Kim, V. Hirsh, T. Mok, et al., “Gefitinib versus Docetaxel in Previously Treated Non-Small Cell Lung Cancer (INTEREST): A Randomised Phase III Trial,” Lancet, Vol. 372, No. 9652, 2008, pp. 1809-1818. doi:10.1016/S0140-6736(08)61758-4

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top